Comment on CMS-2026-1255-0001

Summary: MCG Health, a clinical guidelines publisher, supports the proposed rule to establish interoperable and transparent prior authorization standards for drugs. They advocate for maintaining flexibility for nuanced clinical judgment in electronic workflows and suggest specific improvements regarding step therapy portability, decision timeframes, and standardized denial taxonomies.